Global Vitamin D Market To Grow Vigorously And Reach USD 2398.94 Million by 2032

According to the report published by Zion Market Research, global demand for Vitamin D Market, estimating its value at USD 1432.04 Million in 2023, with projections indicating that it will reach USD 2398.94 Million by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 5.9% over the forecast period 2024-2032. The global market is boosted by increase in cases of osteoporosis in females, increase in awareness of vitamin D deficiency, and rise in prevalence of malnutrition in kids. On the other hand, the vitamin D’s regulatory standards are generating a limitation in the market. The increasing number of government programs and awareness campaigns is predicted to generate new growth opportunities for the development of the market.

The major players in vitamin D market comprise Koninklijke DSM N.V., Taizhou Haisheng Pharmaceutical Co., Ltd., Zhejiang Xinhecheng Co., Ltd., Fermenta Biotech Ltd., Xiamen Jindawei Vitamin Co., Ltd., BASF, Zhejiang Medicine Co., Ltd., Dishman Group., and Zhejiang Garden Biochemical High-Tech Co. Ltd.

Pharmaceuticals Segment Predicted To Power The Global Market In The Years To Come

On the basis of application, the vitamin D market was ruled by the pharmaceuticals section in terms of value. On the other hand, the section is valued more owing to the high price related with the potency level or IU level of vitamin D employed in the pharmaceutical sector. In addition to this, very low amount of vitamin D is employed in pharmaceuticals, owing to its superior quality, and hence, the market is moderately less as compared to applications. Internationally, the market is ruled by the feed & pet food category. The pharmaceuticals section is also expected to develop at the max CAGR, due to its wide employment in injectables, health supplements, and capsules.

The Asia Pacific Market Expected To Develop At The Max CAGR In The Years To Come

The lack of vitamin D is extensive in Asia Pacific, specifically in Southeast and South Asia. Rickets is very ordinary in China and is an outcome of poor consumption of vitamin D. In addition to this, the increase in revenue levels and noteworthy user demand for healthy & nutritional goods are predicted to offer potential prospects for the development and diversification of the area’s functional beverage & food goods, in turn, resulting in development in the usage of vitamin-based goods, and therefore powering the growth of the market.

Browse the full “Vitamin D Market Product (Vitamin D2 and Vitamin D3), By Application (Pharmaceuticals, Functional Food, Beverage, Personal Care, Feed & Pet Food and Others) End-user (Adult, Children and Pregnant women): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032.” Report at https://www.zionmarketresearch.com/report/vitamin-d-market

The global vitamin D ingredients market is segmented as follows:

By analog

• Vitamin D3
• Vitamin D2

By IU strength

• 500,000 IU
• 100,000 IU
• 40 MIU
• Others (1 MIU, 2 MIU, 4 MIU, 10 MIU, 15 MIU, 1,000 IU, and 2,000 IU)

By form

• Dry
• Liquid

By application

• Feed & pet food
• Animal feed
• Pet food
• Pharmaceuticals
• Functional food & beverages
• Personal care

By end user

• Adults
• Pregnant women
• Children

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa